In 2009 the world spent $736 million (in 2024 prices) on tuberculosis research and development. What about in 2024?
As of 2024, funding for tuberculosis research and development (world, million US dollars, 2024 prices) is 872 million: +18% since 2009.
Why it changed
Two things are true at once: funding for tuberculosis research has risen by 18% since 2009, to $872 million in 2024, coming mainly from public research agencies and philanthropic foundations. And new medicines followed: in late 2012 the US approved bedaquiline, the first new TB drug in more than 40 years. After $860 million in 2019, funding fell to $771 million in 2022 and only in 2024 rose past the 2019 level.
Source · Impact Global Health (G-FINDER survey), via Our World in Data CC BY 4.0, Our World in Data; underlying: Impact Global Health (2025) Last reviewed 2026-10-30
See one like this on every new tab.
Progress Tab replaces your new tab with sourced numbers about the world, on topics you pick. Some cards ask you to guess first.
Add to Chrome Free · no account · opens on every new tabAlso available for Firefox →Common questions
What is the source for this number?
Impact Global Health (G-FINDER survey), via Our World in Data. Last reviewed 2026-10-30. CC BY 4.0, Our World in Data; underlying: Impact Global Health (2025).
How has this changed since 2009?
+18% since 2009. As of 2024, funding for tuberculosis research and development (world, million US dollars, 2024 prices) stands at 872 million.
What still isn’t solved?
New medicines followed: in late 2012 the US approved bedaquiline, the first new TB drug in more than 40 years. After $860 million in 2019, funding fell to $771 million in 2022 and only in 2024 rose past the 2019 level.